I. Jungner

发表

Iron metabolism and risk of cancer in the Swedish AMORIS study

L. Holmberg, N. Hammar, G. Walldius, 2013, Cancer Causes & Control.

Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

I. Holme, A. Aastveit, N. Hammar, 2009, Annals of medicine.

High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

I. Holme, A. Aastveit, N. Hammar, 2012, Annals of medicine.

Gunnar Jungner and the Principles and Practice of Screening for Disease.

I. Jungner, M. Engvall, Lars Jungner, 2017, International journal of neonatal screening.

Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study

I. Holme, A. Aastveit, G. Walldius, 2010, Annals of the rheumatic diseases.

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases

H Tunstall-Pedoe, V Tikhonoff, A Hofman, 2007, European Journal of Epidemiology.

Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?

C. Furberg, I. Holme, A. Aastveit, 2006, The American journal of cardiology.

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

A. Keech, G. Walldius, J. Frohlich, 2003, The Lancet.

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

A. Keech, C. Furberg, A. Wägner, 2003, The Lancet.

Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels – The AMORIS study

J. Ärnlöv, A. Carlsson, T. Ivert, 2018, PloS one.

Risk of prostate cancer is not associated with levels of C‐reactive protein and other commonly used markers of inflammation

L. Holmberg, A. Hayday, N. Hammar, 2011, International journal of cancer.

Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS)

I. Holme, A. Aastveit, N. Hammar, 2009, Journal of internal medicine.

Enzymatic Degradation of Desoxyribose Nucleic Acid by Crystalline Desoxyribonuclease

G. Jungner, I. Jungner, L. Allgén, 1949, Nature.

Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow‐up periods in the Apolipoprotein MOrtality RISk study (AMORIS)

I. Holme, A. Aastveit, G. Walldius, 2008, Journal of internal medicine.

Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I--new risk factors and targets for therapy.

G. Walldius, I. Jungner, 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke

G. Walldius, I. Jungner, 2007, Current opinion in cardiology.

Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease.

C. Furberg, I. Holme, A. Aastveit, 2007, The American journal of cardiology.

Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study.

S. Rohrmann, N. Hammar, G. Walldius, 2016, Atherosclerosis.

Cohort Profile: The AMORIS cohort.

U. de Faire, N. Hammar, G. Walldius, 2017, International journal of epidemiology.

Combined effects of brachial pulse pressure and sialic acid for risk of cardiovascular events during 40 years of follow-up in 37 843 individuals

P. Nilsson, J. Sundström, J. Jendle, 2012, Journal of hypertension.

Apolipoprotein B and apolipoprotein A‐I: risk indicators of coronary heart disease and targets for lipid‐modifying therapy

G. Walldius, I. Jungner, 2004, Journal of internal medicine.

Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43 000 Swedish males and females

I. Holme, G. Walldius, I. Jungner, 1992, International journal of clinical & laboratory research.

Association between Levels of C-Reactive Protein and Leukocytes and Cancer: Three Repeated Measurements in the Swedish AMORIS Study

L. Holmberg, N. Hammar, G. Walldius, 2011, Cancer Epidemiology, Biomarkers & Prevention.

High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study☆

I. Holme, A. Aastveit, G. Walldius, 2002 .

The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid‐lowering therapy – a review of the evidence

G. Walldius, I. Jungner, 2006, Journal of internal medicine.

Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study.

L. Holmberg, I. Fentiman, N. Hammar, 2011, European journal of cancer.

Chronic kidney disease and 10-year risk of cardiovascular death

J. Ärnlöv, A. Carlsson, T. Ivert, 2016, European journal of preventive cardiology.

Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease

T. Ivert, N. Hammar, G. Walldius, 2012, Annals of medicine.

Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population

I. Holme, A. Aastveit, N. Hammar, 2012, Annals of medicine.

Inorganic phosphate and the risk of cancer in the Swedish AMORIS study

L. Holmberg, K. Michaelsson, N. Hammar, 2013, BMC Cancer.

Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy.

G. Walldius, I. Jungner, 2005, European heart journal.

Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort

L. Holmberg, N. Hammar, G. Walldius, 2019, Cancer Causes & Control.

Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study

L. Holmberg, K. Michaelsson, N. Hammar, 2013, BMC Public Health.

Serum Urate, Serum Glucose and Diabetes

T. Whitehead, I. Jungner, D. Robinson, 1992, Annals of clinical biochemistry.

Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis.

K. W. Davidson, J. Gallacher, J. Danesh, 2012, International journal of epidemiology.

Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study

L. Holmberg, K. Michaelsson, N. Hammar, 2012, Cancer Causes and Control.

Stroke mortality and the apoB/apoA‐I ratio: results of the AMORIS prospective study

A. Aastveit, G. Walldius, I. Jungner, 2006, Journal of internal medicine.

Creatinine and creatine clearance in the acute stage of paralytic poliomyelitis.

G. Jungner, I. Jungner, 2009, Acta medica Scandinavica.

Disturbances in nitrogen metabolism in the acute stage of paralytic poliomyelitis.

G. Jungner, I. Jungner, 2009, Acta medica Scandinavica.

Effect of anabolic steroids on nitrogen excretion in acute poliomyelitis.

G. Jungner, I. Jungner, 1959, Lancet.

Country of birth-specific and gender differences in prevalence of diabetes in Sweden.

A. Carlsson, N. Hammar, G. Walldius, 2013, Diabetes research and clinical practice.

Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study

L. Holmberg, N. Hammar, G. Walldius, 2017, Oncotarget.

High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study.

I. Holme, G. Walldius, I. Jungner, 1992, Blood pressure. Supplement.

Lipoprotein components and risk of congestive heart failure in 84 740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

I. Holme, A. Aastveit, N. Hammar, 2009, European journal of heart failure.

Lipid Profiles and Risk of Breast and Ovarian Cancer in the Swedish AMORIS Study

L. Holmberg, N. Hammar, G. Walldius, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Low fructosamine and mortality - A long term follow-up of 215,011 non-diabetic subjects in the Swedish AMORIS study.

J. Ärnlöv, A. Carlsson, N. Hammar, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Iron metabolism and risk of cancer in the Swedish AMORIS study

L. Holmberg, N. Hammar, G. Walldius, 2013, Cancer Causes & Control.

Transaminase activity in the serum in acute poliomyelitis.

G. Jungner, I. Jungner, 2009, Acta medica Scandinavica.

Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients.

L. Holmberg, N. Hammar, G. Walldius, 2015, Carcinogenesis.

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel

R. Krauss, S. Humphries, C. Furberg, 2006, Journal of internal medicine.

Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories

Mats Lambe, Hans Garmo, Henrik Møller, 2016, Cancer medicine.

Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study

L. Holmberg, P. Stattin, N. Hammar, 2018, International journal of cancer.

The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study

L. Holmberg, N. Hammar, G. Walldius, 2012, International journal of cancer.

Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study.

L. Holmberg, N. Hammar, G. Walldius, 2012, International journal of molecular epidemiology and genetics.

Prostate cancer risk in the Swedish AMORIS study

L. Holmberg, N. Hammar, G. Walldius, 2011, Cancer.

Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study

L. Holmberg, A. Hayday, N. Hammar, 2011, Cancer Causes & Control.

Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort

N. Hammar, G. Walldius, M. Lambe, 2017, Breast Cancer Research.

Serum Glucose and Fructosamine in Relation to Risk of Cancer

L. Holmberg, N. Hammar, G. Walldius, 2013, PloS one.

Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer

N. Hammar, G. Walldius, M. Lambe, 2011, Cancer Causes & Control.

Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20‐year follow‐up of the Swedish AMORIS cohort

N. Hammar, G. Walldius, W. Ye, 2017, Annals of neurology.

Levels of lipids and apolipoproteins in three cultures.

S. Asgary, N. Sarrafzadegan, A. Aastveit, 2009, Atherosclerosis.

The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk

Curt D. Furberg, Are H. Aastveit, C. Furberg, 2004, Clinical chemistry and laboratory medicine.

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

I. Holme, A. Aastveit, G. Walldius, 2001, The Lancet.

XII. The Clinical Evaluation of the Laboratory Investigations

J. Lindahl, I. Jungner, J. Ström, 2009 .

Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort

L. Holmberg, N. Hammar, G. Walldius, 2017, BMC Cancer.

Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study

L. Holmberg, K. Michaelsson, N. Hammar, 2012, Cancer Causes & Control.

Flavanones from the Heart Wood of Larix decidua Mill. (L. europea D C.).

I. Jungner, N. Nybom, J. Gripenberg, 1952 .

Renal function assessed by two different formulas and incidence of myocardial infarction and death in middle‐aged men and women

T. Ivert, N. Hammar, G. Walldius, 2010, Journal of internal medicine.

Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort

L. Holmberg, N. Hammar, G. Walldius, 2019, Cancer Causes & Control.

Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis

L. Holmberg, N. Hammar, G. Walldius, 2015, BMC Cancer.

Serum inflammatory markers and colorectal cancer risk and survival

L. Holmberg, N. Hammar, G. Walldius, 2017, British Journal of Cancer.

Fructosamine Is a Useful Indicator of Hyperglycaemia and Glucose Control in Clinical and Epidemiological Studies – Cross-Sectional and Longitudinal Experience from the AMORIS Cohort

N. Hammar, G. Walldius, S. Gudbjörnsdottir, 2014, PloS one.

Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

I. Holme, A. Aastveit, N. Hammar, 2010, Atherosclerosis.

Molecular Weight Determination on Thymonucleic Acid Compounds by Dielectric Measurements

G. Jungner, I. Jungner, L. Allgén, 1949, Nature.

Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival

L. Holmberg, N. Hammar, G. Walldius, 2016, Oncoimmunology.

Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials.

I. Holme, G. Walldius, S. Marcovina, 1998, Clinical chemistry.

Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study

L. Holmberg, P. Stattin, N. Hammar, 2018, Cancer Causes & Control.

Lipoprotein(a): levels in a Swedish population in relation to other lipid parameters and in comparison with a male Sri Lankan population.

P. Bjellerup, I. Jungner, S. Mendis, 1995, Clinical biochemistry.

Serum lactate dehydrogenase and survival following cancer diagnosis

L. Holmberg, N. Hammar, G. Walldius, 2015, British Journal of Cancer.

Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis

L. Holmberg, A. Grigoriadis, N. Hammar, 2019, BMC molecular and cell biology.

Gamma-glutamyl transferase and C-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: a prospective cohort study.

L. Holmberg, N. Hammar, G. Walldius, 2012, International journal of molecular epidemiology and genetics.

The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort

L. Holmberg, P. Ross, N. Hammar, 2017, International journal of cancer.

Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study

L. Holmberg, D. Michaud, D. Josephs, 2019, BMC Cancer.

Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies

Mats Lambe, Hans Garmo, Niklas Hammar, 2016, International journal of molecular sciences.

Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study

L. Holmberg, A. Hayday, N. Hammar, 2010, Cancer Causes & Control.

Biochemical laboratory investigations.

I. Jungner, B. Laurent, 2009, Acta medica Scandinavica. Supplementum.

Studies on Lignin. XV. Nitrobenzene Oxidation of Lignin-Resorcinol Condensation Products, Methylated with Diazomethane.

I. Jungner, N. Nybom, B. Leopold, 1952 .

Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS study

N. Hammar, G. Walldius, S. Gudbjörnsdottir, 2018, Diabetes, obesity & metabolism.

Sialic acid and incidence of hospitalization for diabetes and its complications during 40-years of follow-up in a large cohort: the Värmland survey.

P. Nilsson, J. Sundström, J. Jendle, 2014, Primary care diabetes.

Hypercholesterolemia and hypertriglyceridemia—greatest cardiac risk in subjects with high apoB/apoA-I levels

A. Aastveit, G. Walldius, I. Jungner, 2004 .

Lipoproteins and cardiovascular risk

G. Walldius, I. Jungner, C. Furberg, 2003, The Lancet.

Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

I. Holme, A. Aastveit, N. Hammar, 2009, Journal of internal medicine.

Serum biomarkers to predict risk of testicular and penile cancer in AMORIS

A. Ghoshal, N. Hammar, G. Walldius, 2017, Ecancermedicalscience.

Fructosamine is a risk factor for myocardial infarction and all-cause mortality - Longitudinal experience from the AMORIS cohort.

N. Hammar, G. Walldius, I. Jungner, 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort

L. Holmberg, N. Hammar, G. Walldius, 2018, BMC Cancer.

Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study

L. Holmberg, D. Michaud, D. Josephs, 2020, Frontiers in Oncology.

Prevalence of hereditary haemochromatosis in two Swedish urban areas

L. Hallberg, I. Jungner, E. Björn-Rasmussen, 1989, Journal of internal medicine.

Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort

L. Holmberg, N. Hammar, G. Walldius, 2017, BMC Cancer.

Apolipoproteins and prediction of fatal myocardial infarction

I. Holme, A. Aastveit, G. Walldius, 2002, The Lancet.

Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study

L. Holmberg, P. Stattin, N. Hammar, 2018, Cancer Causes & Control.

Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study

L. Holmberg, N. Hammar, G. Walldius, 2012, Journal of cancer epidemiology.

Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study

L. Holmberg, D. Michaud, D. Josephs, 2019, BMC Cancer.

Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort

L. Holmberg, N. Hammar, G. Walldius, 2018, BMC Cancer.

Biomarker-based score to predict mortality in persons aged 50 years and older: a new approach in the Swedish AMORIS study.

L. Holmberg, N. Hammar, G. Walldius, 2012, International journal of molecular epidemiology and genetics.

Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum

L. Holmberg, A. Ghoshal, N. Hammar, 2017, Oncotarget.

Studies in spontaneous hypoglycemia in childhood. Failure to increase the epinephrine secretion in insulin-induced hypoglycemia.

I. Jungner, R. Zetterstrom, O. Broberger, 1959, The Journal of pediatrics.

Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis

L. Holmberg, A. Grigoriadis, N. Hammar, 2019, BMC Molecular and Cell Biology.

The History of the AutoChemist®: From Vision to Reality

H E Peterson, I Jungner, I. Jungner, 2014, Yearbook of Medical Informatics.

The History of the Data Systems AutoChemist® (ACH) and AutoChemist-PRISMA (PRISMA®): from 1964 to 1986

H E Peterson, I Jungner, L Ohlsén, 2014, Yearbook of Medical Informatics.

Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis.

J. Gallacher, J. Danesh, E. Rimm, 2012, International journal of epidemiology.

Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS)

I. Holme, A. Aastveit, N. Hammar, 2009, Journal of internal medicine.